Anti-lag-3 antibodies and compositions
US11834503B2 · kind B2 · utility
0Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2022 |
| Grant date | Dec 5, 2023 |
| Priority date | — |
| Expiry date | Jun 7, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to anti-LAG-3 antibodies and methods of using them in treating diseases and conditions that benefit from modulating LAG-3 activity, e.g., cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.